CClinicalTrials.gg
CompletedNCT03601325Updated Aug 9, 2023

Acute Pancreatitis: Study of Possible Etiologies and Risk Factors Affecting Outcome

An observational study in Pancreatitis, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-09.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

This study is to assess the frequency of different etiologies of acute pancreatitis in our locality \& assess the effect of different risk factors on outcome of the patients.

02

Conditions studied

  • Pancreatitis

Browse trials for

Keywords

  • pancreatitis
03

In context

Pancreatitis

752 studies on the registry are indexed under Pancreatitis; 181 are open to participants now.

This study's enrollment of 300 is above the median of 180 across 277 observational studies indexed under Pancreatitis.

Browse Pancreatitis studies →

Lead sponsor

Assiut University is the lead sponsor of 4,916 studies on the registry; 2,113 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients admitted in assuit university hospital during the period of the study and diagnosed as acute pancreatitis

Inclusion criteria

-

Diagnosis of acute pancreatitis according to the following: the presence of two of the three following criteria:

  • abdominal pain consistent with the disease
  • serum amylase and or lipase greater than three times the upper limit of normal
  • characteristic findings from abdominal imaging Contrast-enhanced computed tomographic (CECT) and or magnetic resonance imaging (MRI) of the pancreas

Exclusion criteria

Exclusion Criteria:

  • No exclusion criteria .
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
300 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The frequency of different etiologies of AP in our locality

    At the end of study, total number of patients of each etiology of acute pancreatitis will be calculated as (Gallstones, Alcohol, triglyceridemia, Idiopathic, ERCP,..)

    Time frame: 1 year

Secondary outcomes

  1. Outcome of the patients according to the Atlanta Classification 2012 revision

    Effect of each risk factor on outcome as progression to mild, moderate severe and severe pancreatitis "according to the Atlanta Classification 2012 revision",

    Time frame: 1 year

  2. Hospital duration of stay

    Effect of each risk factor on hospital duration of stay

    Time frame: 1 year

  3. Rate of transfer to ICU

    Effect of each risk factor on rate of transfer to ICU

    Time frame: 1 year

  4. Mortality

    Effect of each risk factor on mortality

    Time frame: 1 year

07

Study locations

1 site
  • Ahmed Mohammed Abu-Elfatth
    Assiut, 71515, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03601325
Lead sponsor
Assiut University
Responsible party
SMMostafa (Specialist of tropical medicine and gastroenterology, Assiut University) — Principal investigator
First posted
Jul 26, 2018
Start date
Oct 1, 2018
Primary completion
Oct 1, 2022
Completion
Oct 30, 2022
Last update
Aug 9, 2023

Study contacts

Ashraf Osman, MD
study director · Assiut University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion